pI: 3.5882 |
Length (AA): 86 |
MW (Da): 9676 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 86 | 4wfc (B) | 5 | 80 | 25.00 | 0 | 0.16 | 1.11169 | -0.27 |
12 | 86 | 4wfc (B) | 5 | 80 | 31.00 | 0.094 | 0.38 | 1.18659 | -0.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128925)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G25080 | Sas10/Utp3/C1D family protein |
Brugia malayi | Bm1_08360 | nuclear DNA-binding protein C1D |
Brugia malayi | Bm1_08605 | nuclear DNA-binding protein C1D |
Candida albicans | CaO19.5067 | similar to S. cerevisiae LRP1 (YHR081W) nuclear exosome component involved in RNA processing |
Candida albicans | CaO19.12533 | similar to S. cerevisiae LRP1 (YHR081W) nuclear exosome component involved in RNA processing |
Caenorhabditis elegans | CELE_Y51H7C.7 | Protein Y51H7C.7 |
Drosophila melanogaster | Dmel_CG8928 | CG8928 gene product from transcript CG8928-RB |
Echinococcus granulosus | EgrG_000829800 | nuclear nucleic acid binding protein C1D |
Echinococcus multilocularis | EmuJ_000829800 | nuclear nucleic acid binding protein C1D |
Homo sapiens | 10438 | C1D nuclear receptor corepressor |
Loa Loa (eye worm) | LOAG_10180 | nuclear DNA-binding protein C1D |
Mus musculus | ENSMUSG00000000581 | C1D nuclear receptor co-repressor |
Neospora caninum | NCLIV_007420 | nuclear DNA-binding protein, putative |
Oryza sativa | 4345136 | Os08g0270200 |
Plasmodium berghei | PBANKA_1309300 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_1445500 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_1236800 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_118210 | hypothetical protein, conserved |
Saccharomyces cerevisiae | YHR081W | Lrp1p |
Schistosoma japonicum | Sjp_0204090 | Nuclear nucleic acid-binding protein C1D, putative |
Schistosoma mansoni | Smp_159410 | nuclear DNA-binding protein |
Toxoplasma gondii | TGME49_252320 | Sas10/Utp3/C1D family protein |
Trichomonas vaginalis | TVAG_056410 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_252320 | Toxoplasma gondii | Essentiality uncertain | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.